"Leiomyoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A benign tumor derived from smooth muscle tissue, also known as a fibroid tumor. They rarely occur outside of the UTERUS and the GASTROINTESTINAL TRACT but can occur in the SKIN and SUBCUTANEOUS TISSUE, probably arising from the smooth muscle of small blood vessels in these tissues.
| Descriptor ID |
D007889
|
| MeSH Number(s) |
C04.557.450.590.450
|
| Concept/Terms |
Leiomyoma- Leiomyoma
- Leiomyomas
- Fibroid Tumor
- Fibroid Tumors
- Tumor, Fibroid
- Tumors, Fibroid
- Fibromyoma
- Fibromyomas
- Fibroid
- Fibroids
Fibroid Uterus- Fibroid Uterus
- Uterus, Fibroid
- Fibroma, Uterine
- Fibromas, Uterine
- Uterine Fibroma
- Uterine Fibromas
- Fibroids, Uterine
- Fibroid, Uterine
- Uterine Fibroid
- Uterine Fibroids
- Leiomyoma, Uterine
|
Below are MeSH descriptors whose meaning is more general than "Leiomyoma".
Below are MeSH descriptors whose meaning is more specific than "Leiomyoma".
This graph shows the total number of publications written about "Leiomyoma" by people in this website by year, and whether "Leiomyoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 2 | 0 | 2 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 2 |
| 2021 | 3 | 0 | 3 |
| 2022 | 2 | 0 | 2 |
| 2023 | 5 | 0 | 5 |
| 2024 | 6 | 0 | 6 |
| 2025 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leiomyoma" by people in Profiles.
-
The Roles of Non-Coding RNAs in the Pathogenesis of Uterine Fibroids. Cells. 2025 Aug 20; 14(16).
-
Comparative Analysis of Differentially Expressed Long Non-Coding RNA in Pre- and Postmenopausal Fibroids. Int J Mol Sci. 2025 Jul 16; 26(14).
-
Differential Expression of Small Non-Coding RNAs in Uterine Leiomyomas. Int J Mol Sci. 2025 Feb 16; 26(4).
-
The in?vivo effects of knockdown of long non-coding RNA XIST on fibroid growth and gene expression. FASEB J. 2024 Nov 15; 38(21):e70140.
-
The Functional Role of the Long Non-Coding RNA LINCMD1 in Leiomyoma Pathogenesis. Int J Mol Sci. 2024 Oct 27; 25(21).
-
The immune landscape of uterine fibroids as determined by mass cytometry. F S Sci. 2024 Aug; 5(3):272-282.
-
In Vivo Effects of Bay 11-7082 on Fibroid Growth and Gene Expression: A Preclinical Study. Cells. 2024 Jun 24; 13(13).
-
Targeting the long non-coding RNA MIAT for the treatment of fibroids in an animal model. Clin Sci (Lond). 2024 Jun 19; 138(12):699-709.
-
The Effect of Race/Ethnicity and MED12 Mutation on the Expression of Long Non-Coding RNAs in Uterine Leiomyoma and Myometrium. Int J Mol Sci. 2024 Jan 21; 25(2).
-
Therapeutic effects of in?vivo administration of an inhibitor of tryptophan 2,3-dioxygenase (680c91) for the treatment of fibroids: a preclinical study. Fertil Steril. 2024 Apr; 121(4):669-678.